http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106727470-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165 |
| filingDate | 2016-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106727470-B |
| titleOfInvention | Application of the benserazide hydrochloride in the drug of preparation treatment acute inflammation |
| abstract | The present invention relates to application of the benserazide hydrochloride in the drug of preparation treatment acute inflammation, belong to biomedicine technical field.For the present invention by animal experiment study therapeutic effect of the benserazide hydrochloride to acute inflammation, the inflammatory factor that test result shows that benserazide hydrochloride generates lipopolysaccharides induced mice acute inflammation has inhibiting effect.Acute inflammation model is constructed particular by lipopolysaccharide-induced C57BL/6 mouse, it is treated using the benserazide hydrochloride of various concentration, as a result, it has been found that benserazide hydrochloride can reduce the inflammatory factor level and liver tissue lesions' degree generated when C57BL/6 chmice acute inflammation, wherein, the benserazide hydrochloride effect of low dosage is best.The various preparations that benserazide hydrochloride is prepared into clinical needs by adding pharmaceutically acceptable carrier, the beneficial effect is that: new approach is provided to prepare acute inflammation drug. |
| priorityDate | 2016-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 83.